Exact Mass: 502.19598840000003
Exact Mass Matches: 502.19598840000003
Found 189 metabolites which its exact mass value is equals to given mass value 502.19598840000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cycloheterophyllin
Cycloheterophyllin is an extended flavonoid. Cycloheterophyllin is a natural product found in Artocarpus integer and Artocarpus lowii with data available. Cycloheterophyllin is found in fruits. Cycloheterophyllin is isolated from bark of Artocarpus heterophyllus (jackfruit Isolated from bark of Artocarpus heterophyllus (jackfruit). Cycloheterophyllin is found in jackfruit and fruits.
Artonin B
Artonin B is found in fruits. Artonin B is a constituent of Artocarpus heterophyllus (jackfruit) Constituent of Artocarpus heterophyllus (jackfruit). Artonin B is found in fruits.
Isocycloheterophyllin
Isocycloheterophyllin is found in fruits. Isocycloheterophyllin is a constituent of wood of Artocarpus heterophyllus (jackfruit)
Artonin A
Artonin A is found in fruits. Artonin A is a constituent of Artocarpus heterophyllus (jackfruit) Constituent of Artocarpus heterophyllus (jackfruit). Artonin A is found in fruits.
Artonin F
Artonin F is found in breadfruit. Artonin F is a constituent of Artocarpus communis (breadfruit). Constituent of Artocarpus communis (breadfruit). Artonin F is found in breadfruit and fruits.
Isoglobotriaose
C19H34O15 (502.18976140000007)
Isoglobotriaose is a glycosphingolipid found in mammalian tissues; nonepithelial residue in the intestine, spleen, and spleen microsomes. (PMID: 7053385, 893368, 4690582). Globotriaosylceramide receptors bind to Verotoxin 1 (VT1) B subunits from Escherichia coli eliciting human vascular disease as a consequence of specific binding to these receptors on endothelial cell surfaces. (PMID: 10361298, 10353828). Globotriaosylceramides accumulate in patients with Fabry disease. Fabry disease is a X-linked metabolic disorder caused by a deficiency of alpha-galactosidase leading to the systemic accumulation of glycosphingolipids with alpha-galactosyl moieties; glycolipid deposition in endothelial cells leads to renal failure and cardiac and cerebrovascular disease. (PMID: 10339603). Isoglobotriaose is a glycosphingolipid found in mammalian tissues; nonepithelial residue in the intestine, spleen, and spleen microsomes. (PMID: 7053385, 893368, 4690582)
Ac-DEVD-CHO
Artonin N
Gochnatiolide A
Artonin M
Artonin O
Euchretin J
Cycloheterophyllin
artonin F
2,6-dimethoxy-4-(prop-2-enyl)phenyl alpha-L-rhamnopyranosyl-(1<*>6)-beta-D-glucopyranoside
C23H34O12 (502.20501640000003)
(5R,8Z,11Z)-5-(6-O-malonyl-beta-D-glucopyranosyloxy)-6-oxotetradeca-8,11-dienoic acid
C23H34O12 (502.20501640000003)
2,6-dimethoxy-4-[(1E)-prop-1-enyl]phenyl alpha-L-rhamnopyranosyl-(1<*>6)-beta-D-glucopyranoside
C23H34O12 (502.20501640000003)
methoxyeugenol 4-O-rhamnosyl(1->2)glucoside
C23H34O12 (502.20501640000003)
1,4-di-O-beta-D-glucopyranosyl-2-(1,1-dimethylpropenyl)benzene
C23H34O12 (502.20501640000003)
1,5-Bis(beta-D-glucopyranosyloxy)-2-(3,3-dimethylallyl) benzene|1,5-Bis(??-D-glucopyranosyloxy-2-(3,3-dimethylallyl) benzene
C23H34O12 (502.20501640000003)
1,3-di-O-beta-glucopyranosyloxy-4-(1,1-dimethyl-2-propenyl)benzene|JBIR-37
C23H34O12 (502.20501640000003)
Ala Cys Phe Tyr
Ala Cys Tyr Phe
Ala Phe Cys Tyr
Ala Phe Tyr Cys
Ala Tyr Cys Phe
Ala Tyr Phe Cys
Cys Ala Phe Tyr
Cys Ala Tyr Phe
Cys Phe Ala Tyr
Cys Phe Phe Ser
Cys Phe His Pro
Cys Phe Pro His
Cys Phe Ser Phe
Cys Phe Tyr Ala
Cys His Phe Pro
Cys His Ile Met
Cys His Leu Met
Cys His Met Ile
Cys His Met Leu
Cys His Pro Phe
Cys Ile His Met
Cys Ile Met His
Cys Leu His Met
Cys Leu Met His
Cys Met His Ile
Cys Met His Leu
Cys Met Ile His
Cys Met Leu His
Cys Pro Phe His
Cys Pro His Phe
Cys Ser Phe Phe
Cys Tyr Ala Phe
Cys Tyr Phe Ala
Glu Glu Glu Pro
Glu Glu Pro Glu
Glu Pro Glu Glu
Phe Ala Cys Tyr
Phe Ala Tyr Cys
Phe Cys Ala Tyr
Phe Cys Phe Ser
Phe Cys His Pro
Phe Cys Pro His
Phe Cys Ser Phe
Phe Cys Tyr Ala
Phe Phe Cys Ser
Phe Phe Ser Cys
Phe His Cys Pro
Phe His Pro Cys
Phe Pro Cys His
Phe Pro His Cys
Phe Ser Cys Phe
Phe Ser Phe Cys
Phe Tyr Ala Cys
Phe Tyr Cys Ala
His Cys Phe Pro
His Cys Ile Met
His Cys Leu Met
His Cys Met Ile
His Cys Met Leu
His Cys Pro Phe
His Phe Cys Pro
His Phe Pro Cys
His Ile Cys Met
His Ile Met Cys
His Leu Cys Met
His Leu Met Cys
His Met Cys Ile
His Met Cys Leu
His Met Ile Cys
His Met Leu Cys
His Pro Cys Phe
His Pro Phe Cys
Ile Cys His Met
Ile Cys Met His
Ile His Cys Met
Ile His Met Cys
Ile Met Cys His
Ile Met His Cys
Leu Cys His Met
Leu Cys Met His
Leu His Cys Met
Leu His Met Cys
Leu Met Cys His
Leu Met His Cys
Met Cys His Ile
Met Cys His Leu
Met Cys Ile His
Met Cys Leu His
Met His Cys Ile
Met His Cys Leu
Met His Ile Cys
Met His Leu Cys
Met Ile Cys His
Met Ile His Cys
Met Leu Cys His
Met Leu His Cys
Pro Cys Phe His
Pro Cys His Phe
Pro Glu Glu Glu
Pro Phe Cys His
Pro Phe His Cys
Pro His Cys Phe
Pro His Phe Cys
Ser Cys Phe Phe
Ser Phe Cys Phe
Ser Phe Phe Cys
Tyr Ala Cys Phe
Tyr Ala Phe Cys
Tyr Cys Ala Phe
Tyr Cys Phe Ala
Tyr Phe Ala Cys
Tyr Phe Cys Ala
N-Ac-Asp-Glu-Val-Asp-CHO
Isoglobotriaose
C19H34O15 (502.18976140000007)
Isocycloheterophyllin
artonin A
Artonin B
benzene-1,3-dicarboxylic acid,2,2-dimethylpropane-1,3-diol,furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol
C23H34O12 (502.20501640000003)
(6α,8ξ,11β,14ξ,16α,17α)-6,9-Difluoro-17-{[(fluoromethyl)sulfanyl] carbonyl}-11-hydroxy-16-methyl-3-oxoandrost-4-en-17-yl propionate
C25H33F3O5S (502.2000684000001)
[(2R,3R,4R,5R)-4-acetyloxy-1-[tert-butyl(diphenyl)silyl]oxy-2,5-dihydroxy-6-oxohexan-3-yl] acetate
Ac-DEVD-CHO
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors Ac-DEVD-CHO is a specific Caspase-3 inhibitor with a Ki value of 230 pM.
Forxiga
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent D007004 - Hypoglycemic Agents > D000077203 - Sodium-Glucose Transporter 2 Inhibitors C471 - Enzyme Inhibitor > C98083 - SGLT2 Inhibitor
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-3-methoxybenzenesulfonamide
(3R,6aR,8S,10aR)-N-(4-chlorophenyl)-3-hydroxy-8-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(2R,3R,4R,5R)-4-{[(2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(1S,2R,3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxy}oxan-2-yl]oxy}-2,3,5,6-tetrahydroxyhexanal
C19H34O15 (502.18976140000007)
CCG258747
CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1]. CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the μ-opioid receptor. G protein-coupled receptor (GPCR) kinases (GRKs) are attractive targets for the research of heart failure[1].
(16s,17s)-16-(4-hydroxy-3-methoxyphenyl)-17-(hydroxymethyl)-13-isopropyl-7,7-dimethyl-15,18-dioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),2,4,8,11,13-hexaene-6,10-dione
(16r,17s)-16-(4-hydroxy-3-methoxyphenyl)-17-(hydroxymethyl)-13-isopropyl-7,7-dimethyl-15,18-dioxatetracyclo[9.8.0.0³,⁸.0¹⁴,¹⁹]nonadeca-1(19),2,4,8,11,13-hexaene-6,10-dione
(17r)-12,21,23-trihydroxy-8,8,18,18-tetramethyl-5-(3-methylbut-2-en-1-yl)-3,7,19-trioxahexacyclo[15.6.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(23),2(15),4,6(11),9,12,20(24),21-octaen-14-one
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[4-(3-methylbut-2-en-1-yl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy]oxane-3,4,5-triol
C23H34O12 (502.20501640000003)